CureGenetics
Latest round
- Series B
Last raised
- Jan 2022
Total raised
- $77M
Investors
- 8
About CureGenetics
Based in Suzhou, China and established in 2016, CureGenetics is a bio-pharmacy company that developed gene and cells therapy drugs for genetic diseases and tumors, taking the technology of gene edition, virus delivery, macromolecule modification. The company has established cooperation with BI to develop vector delivery for treat liver diseases. The company provides gene edition, vector delivery, and molecular optimization. The gene edition can achieve design of specific gene editing tools for vitro cell therapy and in vivo gene therapy, optimization tools for editing genetic information in the nucleus of specific tissues, and high-performance and safe developed tools for packaged by AAV virus. The virus vector delivery can achieve CRISPR platform to synchronize AAV virus packaging, and AAV virus production platform reducing costs. The molecular optimization includes targeted optimization for screened AAV virus, design optimization for molecules of cell therapy, and innovative design for protein drug molecules. The company plans to accelerate the clinical development of blood and tumor cell therapy products, and to promote the development and international cooperation of innovative serotype screening and gene editing products.
Who invested in CureGenetics
8 investors across 4 rounds
See all investors in CureGenetics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about CureGenetics
Who invested in CureGenetics?
CureGenetics has 8 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has CureGenetics raised?
CureGenetics has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did CureGenetics last raise money?
CureGenetics's most recent round on record is a Series B, in Jan 2022.
What does CureGenetics do?
Based in Suzhou, China and established in 2016, CureGenetics is a bio-pharmacy company that developed gene and cells therapy drugs for genetic diseases and tumors, taking the technology of gene edition, virus delivery, macromolecule modification.
Where is CureGenetics headquartered?
CureGenetics is headquartered in Suzhou, China.
Which VCs invest in companies like CureGenetics?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back biotechnology companies at CureGenetics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like CureGenetics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.